Cargando…
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
OBJECTIVES: To evaluate the protein expression of connexin 43 (Cx43) in primary urothelial bladder cancer and test its association with the histopathological characteristics and clinical outcome. METHODS: A tissue microarray containing 348 tissue samples from 174 patients with primary urothelial car...
Autores principales: | Poyet, Cédric, Buser, Lorenz, Roudnicky, Filip, Detmar, Michael, Hermanns, Thomas, Mannhard, Doris, Höhn, Andrej, Rüschoff, Jan, Zhong, Qing, Sulser, Tullio, Moch, Holger, Wild, Peter J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602233/ https://www.ncbi.nlm.nih.gov/pubmed/26251520 http://dx.doi.org/10.1136/jclinpath-2015-202898 |
Ejemplares similares
-
CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer
por: Wettstein, Marian S., et al.
Publicado: (2015) -
Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2014) -
Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
por: Mortezavi, Ashkan, et al.
Publicado: (2017) -
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer
por: POYET, CÉDRIC, et al.
Publicado: (2015) -
Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study
por: Bieri, Uwe, et al.
Publicado: (2022)